Michael P Lisanti (Amira Osman)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Cognitive Impairment

Cancer Stem Cells

Endoplasmic Reticulum

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Salwa A Elgendy, Mohamed Mohamed Soliman, Heba I Ghamry, Mustafa Shukry Atta, Lina Abdelhady Mohammed, Hend Elsayed Nasr, Badriyah Shadid Alotaibi, Ibrahim Jafri, Samy M Sayed, Michael P Lisanti, Heba A Elnoury
Exploration of Tilmicosin Cardiotoxicity in Rats and the Protecting Role of the Rhodiola rosea Extract: Potential Roles of Cytokines, Antioxidant, Apoptotic, and Anti-Fibrotic Pathways. Toxics 11 (10) (2023)
Medhat Taha, Sara T Elazab, Alaa M Badawy, Abdullah Ali Saati, Naeem F Qusty, Abdullah G Al-Kushi, Anas Sarhan, Michael P Lisanti, Amira E Farage
Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Marco Fiorillo, Fanni Tóth, Matteo Brindisi, Federica Sotgia, Michael P Lisanti
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production. Cells 9 (6) (2020)
Michael P Lisanti, Said M Afify, Ghmkin Hassan, Xiaoying Fu, Akimasa Seno, Masaharu Seno
Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs. Cancers 12 (4) (2020)
Hend M Nawara, Said M Afify, Ghmkin Hassan, Maram H Zahra, Marwa N Atallah, Hager Mansour, Hagar A Abu Quora, Md Jahangir Alam, Michael P Lisanti, Hiroki Kakuta, Hiroki Hamada, Akimasa Seno, Masaharu Seno
Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells. Cancers 12 (6) (2020)